Advancements in Cancer Treatment: What You Need to Know

Oncology is experiencing incredible achievements as we look to the future, thanks to cutting-edge technologies and novel treatments. However, 6 major developments are at the forefront: artificial intelligence (A.I.), genomic medicine, next-generation cancer organoids, nanoparticles, PIPAC (Pressurized Intraperitoneal Aerosol Chemotherapy) and Robotic Surgery.

SHAMIMA BEGUMTECHNOLOGYHEALTH

Shamima Begum

7/23/20243 min read

Advancements in Cancer Treatment: What You Need to Know
Advancements in Cancer Treatment: What You Need to Know

Advancements in Cancer Treatment: What You Need to Know

Cancer is a non communicable disease with a high global incidence. Every day, scientists and researchers throughout the world make groundbreaking advances that reshape the landscape of oncology. These improvements give patients and medical professionals some hope.

Moreover, for decades, chemotherapy, radiotherapy, and surgery have been used to combat this disease. Cancer research has advanced significantly since the advent of tailored medicines and targeted therapies.

We are currently in a transformative period of cancer research, with extraordinary advances paving the door for ground-breaking therapies.

Artificial Intelligence in Oncology: Artificial Intelligence and Machine Learning are computer systems that are constructed and trained to help oncologists and other medical professionals treat cancer patients. These technologies are very important as they can expedite and optimize the process of diagnosis and treatment for the betterment of cancer patients. It is used to visualize medical images for conditions such as mammography for breast cancer and brain tumor scans. Evidence has been presented that in some cases, it can be pretty good at detecting and analyzing the images, surpassing the abilities of an expert doctor.

Genomic Medicine: Genomic medicine is the study and analysis of a patient's genetic information, primarily DNA, in order to better understand the hereditary basis of diseases such as cancer. Next-Generation Sequencing (NGS) was developed approximately 10 years ago, making it considerably easier and less expensive to read all of the genetic information in a person's DNA Whole Genome Sequencing (WGS). This innovation increased the availability of WGS for study and treatment of cancer patients. The 100,000 Genome Project was established in the United Kingdom, and it uses WGS to examine the DNA of almost 15,000 cancer patients. They compared the patient's normal genetic information (germline) with the genetic makeup of their tumor. The research supplied patients and their families with significant information, helping them to better understand the genetic cause of their cancer and how to treat it.

Next-Generation Cancer Organoids: Next-generation cancer organoids are advanced 3D models of cancer cells that closely resemble the properties and activity of tumors in the human body. Organoids are grown in a laboratory using cancer cells from the patient. These models are effective because they preserve the important characteristics of the original tumor, such as its genetics, proteins, and appearance, while allowing scientists to change the genes and environment in ways that were previously impossible.

Nanoparticles: Nanoparticles are microscopic particles that are specifically engineered to deliver medications or therapeutic substances to cancer cells. Nanomedicine includes the use of nanoparticles for cancer treatment. This field investigates how nanotechnology, including oncology, can enhance disease detection, treatment, and monitoring. Their small size makes them more stable and safe for the body. They can also stay in the cancer region for longer periods of time, allowing the medications to take effect. They can be tailored to specifically target malignant cells, decreasing adverse effects and increasing therapy efficacy.

A New Chemotherapy Delivery Technique (Pressurized Intraperitoneal Aerosol Chemotherapy): Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) is a promising approach of treating advanced abdominal malignancies. Chemotherapy medications are administered directly into the abdominal cavity as an aerosol in PIPAC, which targets and concentrates the treatment of cancers in this region. This method has considerable promise for enhancing the efficacy of abdominal cancer treatment.

Robotic Surgery: Robotic arms enable precise, minimally invasive procedures for cancer removal. Robotic surgery allows for rapid recovery and return to normal life. Robotic arms may appear futuristic, but their precise motions can make a significant difference in removing malignant cells while avoiding harm to healthy tissues.

Conclusion:

Researchers are currently investigating which molecules are essential for cell communication, which could aid in the creation of new Immunotherapy’s that help the body fight cancer rather than introducing poisons that are damaging to the entire body. Planning accurate, individualized cancer treatment is a collaborative effort. By working together, our cancer experts can discover targetable mutations for immunotherapy and determine the most effective treatment timetable and technique.

Links